Making an educated treatment decision begins with the stage, or progression, of the disease. The stage of multiple myeloma is one of the most important factors in evaluating treatment options.
A Burgundy Ribbon brings awareness to Multiple Myeloma. Support friends and family affected by Multiple Myeloma with Burgundy Wristbands, Car Magnets, Bracelets, Necklaces, Gifts and much more. Take advantage of Group and Discount Pricing on many popular items. Order for friends or use for benefits and fundraisers! Don't forget that March is Multiple Myeloma Awareness Month!
3. Rajkumar SV, Harousseau J-L, Durie B, et al. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Lancet Oncol. 2011;117:4691-5.
Every multiple myeloma patient is different. The cancer experts at Cancer Treatment Centers of America ® (CTCA) have extensive experience in properly staging and diagnosing the disease, and developing a treatment plan that's tailored to your specific type of multiple myeloma.
This is Cancer.Net’s Guide to Multiple Myeloma. Use the menu below to choose the Overview/Introduction section to get started. Or, you can choose another section to learn more about a specific question you have. Each guide is reviewed by experts on the Cancer.Net Editorial Board , which is composed of medical, surgical, radiation, gynecologic, and pediatric oncologists, oncology nurses, physician assistants, social workers, and patient advocates.
In some patients, large amounts of myeloma protein can cause the blood to “thicken.” This thickening is called hyperviscosity. It can slow blood flow to the brain and cause:Wiki info
In dogs, multiple myeloma accounts for around 8% of all haemopoietic tumors. Multiple myeloma occurs in older dogs, and is not particularly associated with either males or females. No breeds appear overrepresented in case reviews that have been conducted. Diagnosis in dogs is usually delayed due to the initial non specificity and range of clinical signs possible. Diagnosis usually involves bone marrow studies, X-rays, and plasma protein studies. In dogs, protein studies usually reveal the monoclonal gammaglobulin elevation to be IgA or IgG in equal incidence. In rare cases the globulin elevation is IgM, which is referred to as Waldenström's macroglobulinemia. The prognosis for initial control and return to good quality of life in dogs is good. 43% of dogs started on a combination chemotherapeutic protocol achieved complete remission. Long-term survival is normal, with a median of 540 days reported. The disease eventually recurs, becoming resistant to available therapies. The complications of kidney failure, sepsis, or pain can lead to an animal's death, frequently by euthanasia.
Related pins: · Environmentalism · Leucosolenia Diagram ·